Health and life sciences consultancy, Newmarket Strategy, has added another NHS and government leader to its top team. Robert Kettell, currently the NHS’s Director of Medicines Negotiation, will join Newmarket as…
The Future of Life Sciences event brought together leaders from across the NHS, government, academia, and industry to tackle one of the UK’s greatest opportunities—and challenges: unlocking the full potential…
One of the main messages outlined in the ‘Lord O’Shaughnessy review on commercial clinical trials’ was the economic and financial value to the UK. The review's own research showed that…
NHS England and NICE have published a consultation document which sets out proposals to move towards a more rules-based, integrated, and predictable pathway for the evaluation, funding, and commissioning of…
Prime Minister Rishi Sunak wrong-footed political commentators and analysts yesterday by calling a General Election on the 4th of July. The decision looks to have been driven by better economic…
Today the National Institute for Health and Care Research (NIHR) in collaboration with the Office for Life Sciences (OLS) and the National Institute for Health and Care Excellence (NICE), opened…
The UK’s health and care system produces a vast amount of data that can support research and deliver improvements in the quality of care patients receive. Primary care data are…
In November, Newmarket Strategy hosted a roundtable discussion on the Transformation of the Lung Cancer Pathway in the NHS. This event brought together leading academics, clinicians, and industry partners, providing…